期刊文献+

放射外科治疗脑深部恶性胶质瘤疗效分析 被引量:1

The Outcome of Deep Situated Malignant Gliomas Treated with Radiosurgery
下载PDF
导出
摘要 目的:研究直线加速器放射外科治疗脑深部恶性胶质瘤的疗效。方法:采用直线加速器放射外科治疗脑深部恶性胶质瘤58例,肿瘤平均体积12.08cm3,平均剂量19.42Gy。结果:随访期内44.8%肿瘤缩小,间变性星型细胞瘤MTP为15个月,胶质母细胞瘤MTP为9个月。1年肿瘤无进展生存率为37.9%,预期生存率为79.3%。2年肿瘤无进展生存率为10.3%,预期生存率20.6%。Cox回归分析等中心数和肿瘤体积对TTP有显著影响,而适形指数对患者生存期有显著影响。并发症发生率44.8%,脑水肿加重中位时间8个月,症状性脑水肿发生率31.0%。结论:直线加速器放射外科治疗脑深部恶性胶质瘤,可控制肿瘤生长,延长患者生存期。 Objective:To analysis the prog no sis for malignant gliomas treated with linac radiosurgery.Methods:58patient s with deep situated malignant glioma treated with linac radio-surgery,aged from7to70years,28anaplastic astrocytomas(AA)and30glioblastomas(GBM)w ere analysed.The mean volume of tumor was12.08cm 3 ,and mean prescription dose for linac radio-surgery was19.42Gy.Resul ts:44.8percent tumors shrank in follow-up.Median time-to-tumor progres sion(MTP)was10months,15months for AA and9months for GBM.The progression-free probability was37.9percent at1year and10.3percent at2years.M edian survival was22.5months for AA,13months for GBM and15months for al l patients.The survival probability was79.3percent at1year and20.6per cent at2years.Isocenter numbers and tumor volume were the prognostic factors for time-to-tumor progression,but conformity index was prognostic fac-tor for survival by Cox regression analysis.Complication appeared in44.8percent patients and the median interval of complication onset was8months.Symptomati c cerebral edema was ob-served in31.0percent patients.Conclusion:Linac radiosurgery can effectively improve MTTP and elongate survival for deep situate d malignant gliomas.Isocenter numbers and tumor volume are the prognostic fac tors for MTP,and conformity index is prognostic factor for survival.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第6期409-412,共4页 Chinese Journal of Clinical Oncology
关键词 放射外科 胶质瘤 直线加速器 Radiosurgery Glioma Accelerator
  • 相关文献

参考文献10

  • 1[1]Kondziolka D, Somaza S, Martinez AJ, et al. Radioprotective effects of the 21-aminosteroid U-74389G for stereotactic radiosurgery[J]. Neurosurgery, 1997,41:203~208
  • 2[2]Shrieve DC, Alexander E, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome[J]. J Neurosurg, 1999,90: 72~77
  • 3[3]Hodgson DC, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain rumors[J]. Int J Radiat Oncol Biol Phys, 2001,50:929~935
  • 4[4]Buatti JM, Bova FJ, Friedman WA, et al. Prelimary experience with framless stereotactic radiotherapy [J]. Int J Radiat Oncol Biol Phys, 1998,42:591~599
  • 5[5]Chamberlain MC, Barba D, Kormanik P, et al. Stereotactic radiosurgery for recurrent gliomas[J]. Cancer, 1994,74: 1342~1347
  • 6[6]Prados MD, Wara WM, Sneed PK, et al. Phase Ⅲ trial of accelerated hyperfractionation with or without difluromethylornithine versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme[J]. Int J Radiat Oncol Biol Phys, 2001,49:71~77
  • 7[7]Regine WF, Patchell RA, Strottmann JM, et al. Preliminary report of a phase Ⅰ study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas[J]. Int J Radiat Oncol Biol Phys,2000,48:421~426
  • 8[8]Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans[J]. J Neurosurgery, 2000,93(S3):219~222
  • 9[9]Nakamura JL, Verhey LJ, Smith V, et al. Dose conformity of gamma knife radiosurgery and the risk factors for complications[J]. Int J Radiat Oncol Biol Phys, 2001,51:1313~1319
  • 10[10]Kalapurakal JA, Silverman CL, Akhtar N, et al. Intracranial meningiomas: factors that influence the development of cerebral edema after stereotactic radiosurgery and radiation therapy [J]. Radiology, 1997,204:461~465

同被引文献10

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部